SEARCH RESULTS FOR: "Tag: AMGN"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(4)
2018(1)
2017(17)
2016(11)
2015(12)
2014(1)
CATEGORIES
Analyst Downgrades(6)
Analyst Update(6)
Analyst Upgrades(3)
Buzz Stocks(6)
By the Numbers(1)
Expectational Analysis(1)
General(6)
Indexes and ETFs(1)
Intraday Option Activity(5)
Market Recap(2)
Midday Market Check(2)
Opening View(2)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(10)

7/22/2019 3:12 PM
Stocks are mixed at midday, but little changed overall as investors anticipate a few big names in the earnings confessional later this week. Three stocks on Wall Street's radar today are biotech name...
6/3/2019 2:13 PM
While the Dow is currently trading around breakeven, the tech-rich Nasdaq is down triple digits on regulation concerns for FAANG stocks. Two stocks that have also captured Wall Street's attention tod...
3/15/2019 9:40 AM
Brokerage firm BMO just began coverage on Amgen, Inc. (NASDAQ:AMGN) and Gilead Sciences, Inc. (NASDAQ:GILD), expecting major upside from both stocks. Let's take a closer look at the bull notes, alon...
1/28/2019 2:47 PM
The Dow is getting wrecked today as Caterpillar (CAT) and chip stocks sell off. Biotech name Amgen, Inc. (NASDAQ:AMGN) and video game retailer GameStop Corp. (NYSE:GME) are under pressure, but drugma...
6/5/2018 10:14 AM
The Food and Drug Administration (FDA) just approved Fulphila, a cancer infection treatment developed by Mylan N.V. (NASDAQ:MYL) and India-based Biocon (BION). The drug will be launched in the coming ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center